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ABSTRACT:Opioidreceptors,likeothermembersoftheGprotein-coupledreceptor(GPCR)family,havebeen
shown to associate to form dimers and/or oligomers at the plasma membrane. Whether this association is
stable or transient is not known. Recent compelling evidence suggests that at least some GPCRs rapidly
associate and dissociate. We have recently calculated binding affinities from free energy estimates to predict
transient association between mouse delta opioid receptor (DOR) protomers at a symmetric interface
involving the fourth transmembrane (TM4) helix (herein termed “4” dimer). Here we present disulfide cross-
linking experiments with DOR constructs with cysteines substituted at the extracellular ends of TM4 or TM5
that confirm the formation of DOR complexes involving these helices. Our results are consistent with the
involvement of TM4 and/or TM5 at the DOR homodimer interface, but possibly with differing association
propensities. Coarse-grained (CG) well-tempered metadynamics simulations of two different dimeric
arrangements of DOR involving TM4 alone or with TM5 (herein termed “4/5” dimer) in an explicit
lipid-water environment confirmed the presence of two structurally and energetically similar configurations
of the 4 dimer, as previously assessed by umbrella sampling calculations, and revealed a single energetic
minimum of the 4/5 dimer. Additional CG umbrella sampling simulations of the 4/5 dimer indicated that the
strength of association between DOR protomers varies depending on the protein region at the interface, with
the 4 dimer being more stable than the 4/5 dimer.
Opioid receptors (ORs)
1 are members of the G protein-
coupled receptor (GPCR) superfamily. They play a major role
in the control of nociceptive pathways, but they also modulate
neuroendocrine physiology, mood, stress, appetite, immune
responses, and autonomic functions, including respiration and
thermoregulation. On the basis of radioligand binding profiles,
ORs can be classified into three major subtypes: mu (MOR),
delta (DOR), and kappa (KOR) receptors (1). Like several other
members of the GPCR family (2), opioid receptors have been
shown to interact among themselves at the plasma membrane to
form dimers and/or oligomers (3-11). However, the extent to
which these interactions are stable and/or specific is unknown.
Prevailing views about the static nature of GPCR dimers have
recently been challenged by compelling evidence from imaging
studies. A recent single-molecule study using total internal
reflection fluorescence microscopy showed transient formation
of a typical family A GPCR, the M1 muscarinic acetylcholine
receptor, in living cells, on the time scale of 1 s (12). Recent
fluorescence recovery after photobleaching (FRAP) studies of
β1-adrenoceptors (13) and dopamine D2 receptors(14) also were
consistent with interactions of these GPCRs being transient.
Using experimental measurements of the diffusion coefficient
of a protomeric opioid receptor (15), along with free energies
reconstructed from umbrella sampling of DOR dimers involving
TM4 centered at residue V181
4.58 [where the superscript refers to
the Ballesteros-Weinstein generic numbering scheme (16)], we
were recently able to calculate the association rate and dimeriza-
tion constant of so-called “4” dimers of DOR (17). These
calculated values allowed us to estimate a lifetime of ∼4.4 s for
DOR dimers within an explicit palmitoyloleoylphosphatidylcho-
line (POPC)/10% cholesterol/water environment (17), in rough
agreement withsingle-molecule experimental values obtained for
the M1 muscarinic receptor (12).
Although the degree ofspecificity of these interactions andthe
underlying mechanisms [e.g., conserved motifs or hydrophobic
mismatch? (18)] are not known, the proposed short life span of
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DOR homodimers could still be sufficient for them to exert
unique pharmacologicalfunctions.Thus,understanding indetail
the interaction between DOR protomers is extremely important,
because it might inform the rational design of novel selective
analgesic drugs targeting oligomeric receptors.
Here, we have investigated possible interfaces in DOR homo-
dimeric complexes by means of an integrated experimental-
computational approach aimed at selecting energetically favor-
able dimeric models among all different possibilities amenable
to TM4 or TM5 helices. Our focus on these helices was based
on a large body of literature suggesting a direct primary involve-
ment of lipid-exposed surfaces of TM4 and/or TM5 in the
dimerization/oligomerization interfaces of several GPCRs, in
particular: dopamine D2 receptor (D2R) homodimer (19-22),
serotonin 5-HT4 receptor homodimer (23), serotonin 5-HT2C
homodimer (24), R1b-adrenoceptor homodimer (25, 26), C5a
receptor homodimer (27), chemokine CCR5 homodimer (28),
serotonin 5-HT2A-metabotropic glutamate receptor 2 hetero-
dimer (29), secretin (30), and corticotropin releasing hormone-
VT2argininevasotocinreceptorheterodimer(31).Weperformed
bioluminescence resonance energy transfer (BRET) experiments
to confirm DOR interactions in our experimental system, as well
assubsequentcross-linkingexperimentsonDORconstructswith
substituted cysteines at the extracellular ends of TM4 and TM5.
Since the DOR homodimer interface could not be defined
unambiguously on the basis of the few contact points implied
by experiments, we conducted Gaussian-biased MD simulations
to obtain free energy estimates of all possible dimeric configura-
tions around those specific contact points and to ensure that
identified lowest-energy minima represent the most favorable
energetic configurations satisfying the experimental constraints.
Specifically, guided by the experimental results, we conducted
coarse-grained(CG)well-temperedmetadynamicssimulationsof
pairs of mouse DOR protomers facing one another at the
identified cross-linking positions in TM4 or TM5 within an
explicit lipid-water environment. Using reaction coordinates
that describe the relative position of the interacting protomers,
we have explored alternative 4 or “4/5” dimeric arrangements of
DORcenteredatthesespecificpositionsandidentifiedtheirmost
favorable energetic minima. Finally, CG umbrella sampling
simulationsofthe4/5dimerwereconducted toassessthestability
ofthisassociationcomparedtotheassociationofthe4dimer(17).
MATERIALS AND METHODS
Receptor Constructs and Transfection. For cross-linking
experiments, cysteine mutations were generated in the wild-type
(WT) mouse DOR, epitope-tagged at the N-terminus with a
signal peptide followed by a Myc tag (32). Mutations were
confirmed by DNA sequencing, subcloned into the pcDNA5/
FRT/TO expression vector (Invitrogen), and stably expressed in
Flp-In T-REx HEK293 cells as described previously (32). For
BRET experiments, DOR, C-terminally tagged with either full-
length mVenusor RenillaLuciferase8 (RLuc8), wassubcloned in
the pcDNA 3.1 expression vector, sequenced, and transiently
transfected in HEK293T cells using polyethylenimine (PEI)
(Polysciences Inc.) (22). Experiments were performed 48 h post-
transfection.
G protein-coupled receptor kinase 3 (GRK3) constructs con-
tained amino acids G495-L688 of bovine GRK3 (NP_776925;
also known as β-adrenergic receptor kinases 2 or βARK2),
preceded by a myristic acid attachment peptide (mas;
MGSSKSKTSNS) (masGRK3-ct). The stop codon of GRK3
was replaced with a GGG linker, which was followed by
Rluc8 (33). Gγ2-V was expressed by a plasmid encoding amino
mVenus fused to a GGSGGG linker and the N-terminus of
human Gγ2. The BRET donor and acceptor, masGRK3-ct-
RluC8 and Gγ2-V, respectively, were transiently cotransfected
with GRi1 and Gβ1 along with the DOR (WT or the specified
mutants) using PEI. BRET-based activation experiments were
performed 48 h post-transfection.
BRET. The BRET experiments were performed with cells in
suspension and were quantified with a Pherastar (BMG) (22).
Briefly, BRET titration experiments were performed with cells
coexpressing a constant amount of DOR-RLuc8 and increasing
amounts of DOR-mVenus. The BRET signal was determined by
quantifying and calculating the ratio of the light emitted by
mVenus (510-540 nm) over that emitted by RLuc8 (485 nm) for
BRET. The net BRET values were obtained by subtracting the
background from cells expressing RLuc8 alone. BRET competi-
tion experiments were performed in the presence of untagged
receptor that was coexpressed with DOR-RLuc8 and DOR-
mVenus in HEK293 T cells (22). Activation assays were per-
formed as described with the agonist SCN-80 (33).
Binding. Whole cells stably expressing the specified DOR
construct were suspended in 1 mL of buffer A [25 mM HEPES,
140 mM NaCl, 5.4 mM KCl, 1 mM EDTA, and 0.006% bovine
serum albumin (pH 7.4)]. Cells were diluted 50-fold with buffer
A. [
3H]Naltrindole (Perkin-Elmer) binding was performed in
duplicate 1.1 mL microtube strips with eight different concentra-
tionsof[
3H]naltrindolebetween50and1000pMinbufferAwith
100 μL of the cell suspension in a final volume of 250 μL. The
mixture was incubated at room temperature for 4 h and then
filtered using a Brandel cell harvester through Whatman 934AH
glass fiber filters (Brandel) pretreated with 0.2% PEI. The filter
was washed twice with 1 mL of 10 mM Tris-HCl and 120 mM
NaCl (pH 7.4). Nonspecific [
3H]naltrindole binding was assessed
in the presence of 10 μM naloxone. The data were fit to a
saturation binding curve using nonlinear regression analysis in
GraphPad Prism.
Flow Cytometry Analysis. To assess the surface expression
of each receptor construct, flow cytometry analysis was per-
formed on WT or mutants stably expressed in Flp-In T-REx
HEK293 cells using an Accuri C6 Flow Cytometer system
(AccuriCytometers).Thecellswereharvested48hpost-transfec-
tion, washed, and resuspended in phosphate-buffered saline
(PBS). Cells were incubated at room temperature for 30 min
with a monoclonal anti-Myc antibody (1:500) (Hybridoma
Facility, Mount Sinai, NY), washed, and incubated with a
secondary anti-mouse antibody labeled with Alexa Fluor-(AF)
647 (1:500) (Invitrogen) on ice. Analysis was based on light
scatter, and fluorescence signals produced from laser illumina-
tionat640nm.Signalscorrespondingtoforwardandsidescatter
andfluorescencewereaccumulated;thefluorescencesignalswere
screened using FL-4 (675 nm filter). Threshold levels were set to
eliminate detection of cell debris; 10000 events were collected at
the medium rate setting.
Cross-Linking. The cross-linking reagents CuSO4 and 1,10-
phenanthroline (CuP) in a 1:3 molar ratio or mercuric chloride
(HgCl2) were applied to intact adherent Flp-In T-REx HEK293
cells stably expressing the indicated cysteine mutants for 10 min
at25 C.Cross-linkingwasconductedafterinductionofreceptor
expressionwith1μg/mLtetracyclineovernight.Thecross-linking
reaction was stopped by washing the cells twice with PBS1684 Biochemistry, Vol. 50, No. 10, 2011 Johnston et al.
followed by the addition of 20 mM N-ethylmaleimide (NEM).
The cells were harvested and extracted (21). Twenty micrograms
of protein was loaded per sample, and sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and immuno-
blotting using the anti-Myc rabbit polyclonal antibody (1:800,
Santa Cruz Biotechnology) were performed (21).
Molecular Modeling. In the absence of available crystal
structuresofopioidreceptors,molecularmodelingwasemployed
to generate all-atom structural models of DOR protomers from
Musmusculus,usingthesamestrategywerecentlyreportedinthe
literatureforhumanDOR(34).Briefly,webuilttheTMregionof
mouseDORbyhomologymodelingusingthecrystalstructureof
theβ2adrenergicreceptorat2.4A ˚ resolution(ProteinDataBank
entry 2RH1) (35), and a sequence alignment based on conserved
residues and motifsthatarepresentinfamilyAGPCRs asinputs
to Modeler 9v3 (36). The loop regions were built ab initio using
Rosetta 2.2 (37), and the procedure described in ref 34.T h e
protein N-terminus (residues 1-44) and C-terminus (residues
335-372) were not included in the models. Pairs of the resultant
DOR models were placed facing one another at putative symme-
tricalinterfacesinvolvingTM4andresidueV181
4.58(the4dimer)
or TM4 and TM5 and residue T213
5.38 (the 4/5 dimer).
Residues inthisworkare identified according to theirposition
inthemouseDORsequenceand,whenappropriate,accordingto
the Ballesteros-Weinstein N1.N2 notation (16), reported as a
superscript. In this notation, the first number (N1) refers to the
TMhelixinquestionandthesecondnumber(N2) totheposition
of the residue in the sequence relative to the most conserved
residue in the TM helix, which is assigned a value of 50.
Molecular Dynamics Simulations. The pairs of all-atom
DOR models were converted to CG representations, as defined
by the Martini CG force field (38, 39), in which a single bead
represents approximately four heavy atoms. To maintain the
integrity of the secondary structure of the CG protomers, an
internal elastic network was applied to the backbone beads of
each residue, according totheirsecondary structure, as described
in ref 17.
All simulations were performed using GROMACS version
4.0.5 (40) with the Plumed plug-in (41). The CG dimers were
embedded in a CG POPC membrane patch containing 10%
cholesterol.Thismembranepatchhadpreviouslybeenallowedto
self-assemble, over a period of 100 ns, from a box containing
randomly oriented CG POPC, cholesterol, and water beads, in a
manner similar to that described in ref 17. Each of the CG DOR
dimers was embedded in this membrane using the inflation-
deflation protocol as described by Tieleman and colleagues (42).
Receptorswereoriented suchthat the vector joining their centers
ofmass(COM)wasalongthediagonalofthemembraneplaneto
maximize the space available for subsequent rearrangement of
the protomers. The DOR pairs and the membrane were then
solvated, and counterions were added to neutralize the systems.
These systems were energy minimized and equilibrated by
performing cycles of molecular dynamics (MD) under succes-
sively relaxed position restraints (1000, 100, 10, and 0 kJ mol
-1
nm
-2) for a total of 10 ns. Each of the unrestrained systems was
then simulated for an additional 50 ns, and their equilibration
was checked by monitoring the root-mean-square deviation
(rmsd) of the TM regions of the proteins.
Metadynamics Simulations. The free energy surface for
each ofthe two putative dimer interfacesofDORinvolvingTM4
withor without TM5 (termed 4/5and4 dimers, respectively) was
investigatedusingwell-temperedmetadynamicssimulations(43).
The collective variable (CVs) used to describe the relative posi-
tion of interacting protomers DOR1 and DOR2 during simula-
tionaredepictedinFigure1Aforthe4dimerandinFigure1Bfor
the 4/5 dimer. Specifically, the relative position of the two
protomers was described by (i) the distance r between the COMs
(CDOR1 and CDOR2) of the two TM regions of protomers DOR1
and DOR2, (ii) the rotational angle θDOR1, defined by the
projection onto the plane of the membrane of the COM of
TM4DOR1(or TM4/5DOR1forthe4/5dimer),the CDOR1,andthe
CDOR2, and (iii) the equivalent rotational angle θDOR2. Angles
were calculated as arccosines of the inner product of the normal-
ized vectors connecting the projections onto the plane of the
membraneoftheCOMsofTM4(orTM4andTM5),andthetwo
helical bundles.
To aid simulation convergence, we restricted the rotational
and translational movement of the entire DOR dimer relative to
the simulation cell. Specifically, we applied harmonic restraining
potentials centered at zero, with a force constant k of 200 kJ
mol
-1 nm
-2, to both the distance from the CDOR1 projection to
thecenterofthez=0planeofthesimulationboxandthedistance
from the CDOR2 projection to the diagonal thereof.
Hills were applied only to the angle CVs (i.e., θDOR1 and
θDOR2). The initial height of the biasing Gaussians in the well-
tempered metadynamics algorithm was set to 0.5 kJ/mol (∼0.12
kcal/mol),withabiasfactorof15.Toensureathoroughexplora-
tionofthepossibleinterfacesbetweentwoDORdimersinvolving
either residue V181
4.58 or T213
5.38 on a reasonable time scale, we
limited the sampling of the two rotational angles, θDOR1 and
θDOR2,t oa n∼25  interval for simulations of the 4 dimer and to
an ∼17  interval for the simulations of the more constrained
4/5 dimer, using upper and lower steep repulsive restraining
potentials. The starting values of the angles were as follows:
θDOR1 ∼ 18  and θDOR2 ∼ 25  in the 4 dimer, and θDOR1 ∼ 26 
and θDOR2 ∼ 22  in the 4/5 dimer. The upper and lower limits
were set equidistant from these starting values. The values of
FIGURE 1: Reactioncoordinatesusedtodescribetherelativeposition
of interacting protomers DOR1 and DOR2 during simulation,
superimposed on schematic representations of the (A) 4 and (B) 4/5
dimeric arrangements of DOR. Each circle represents a TM helix,
and the two protomers are distinguished by different shades of gray.
The relative position of the two protomers was described by (i) the
distance r between the COMs (CDOR1 and CDOR2) of the two TM
regions of protomers DOR1 and DOR2, (ii) the rotational angle
θDOR1, defined by the projection onto the plane of the membrane of
the COM of TM4DOR1 or TM4/5DOR1,t h eCDOR1, and the CDOR2,
and (iii) the equivalent rotational angle θDOR2.Article Biochemistry, Vol. 50, No. 10, 2011 1685
these parameters were chosen after an extensive grid search of
parameter ranges (data not shown).
Two 1.5 μs well-tempered metadynamics simulations were
performed, with a time step of 20 fs, for each of the two DOR
homodimers, i.e., 4 or 4/5. Convergence of these simulations was
assessed by monitoring the height of the biasing hills applied
during simulation: this height decreases as the wells in the free
energy surface are filled up, reaching a value of zero when the
simulation is converged. Plots of the hill heights for the 4 and 4/5
dimers are shown in panels A and B of Figure S1 of the
Supporting Information, respectively, and indicate that the hill
heights are very close to zero after several hundred nanoseconds.
Periodic boundary conditions were employed, and electro-
static and van der Waals interactions were cut off and used in
their shifted forms. Temperature and pressure were maintained
by coupling to baths using the V-rescale (44) and Berendsen (45)
algorithms, respectively. A reference temperature of 300 K and a
coupling constant of 1 ps were used for the V-rescale algorithm,
and the Berendsen algorithm employed a coupling constant of
2 ps to a reference pressure of 1 bar.
Conversion of Lowest-Energy CG Structures to All-
Atom Representations. We used the method of Rzepiela and
colleagues (46) to convert the lowest-energy structures of the 4
and 4/5 dimers of DOR from each of the CG metadynamics
simulations back to an atomistic representation. This method
employs a simulated annealing MD simulation in which the CG
and atomistic structures are coupled via restraints. The resulting
all-atom structures were then embedded into a pre-equilibrated
all-atom membrane and solvated in a fashion similar to that
described above for the CG systems and as in ref 42.T h e s e
systems were energy minimized and equilibrated by performing
cyclesofMDundersuccessivelyrelaxedpositionrestraints(1000,
100, 10, and 0 kJ mol
-1 nm
-2) for a total of 10 ps. A further 1 ns
of unrestrained simulation was used, and analysis of interproto-
mer contacts was performed on these systems. This multiscale
approach allows us to consider atomic details of side chain
interactions that are not well resolved in the CG simulations.
Umbrella Sampling Simulations. Simulations of the 4/5
dimer of DOR with the interacting protomers at different
distances were performed according to the protocol described
in detail in ref 17. To keep the exploration to 4/5 dimeric
configurations of DOR exhibiting symmetric contacts between
residues at position 5.38, the two rotational angles, θDOR1 and
θDOR2, were constrained to an ∼17  interval around theircenters
by steep repulsive potentials, in a manner similar to the metady-
namics simulations described above. The Weighted Histogram
Analysis Method (WHAM) code from the Grossfield Lab
(http://membrane.urmc.rochester.edu/content/wham) was used
to derive the free energy from these simulations as a function of
the distance between the COMs of the protomers.
Thermodynamics and Kinetics. The dimerization constant
of the 4/5 dimer of DOR in a POPC/10% cholesterol/water
environment was calculated using the free energy estimates
resulting from the umbrella sampling simulations, and an ap-
proach originally described by Roux and co-workers (47-49).
We recently used this approach to predict the dimerization
constant of the 4 dimer of DOR and reported the details of its
formulation elsewhere (17). The dimerization constant of the 4/5
dimer of DOR calculated here was then used to calculate the
dissociation rate and average lifetime of this particular confor-
mational arrangement. The equations used to calculate these
values are reported in detail elsewhere (17).
RESULTS
Biophysical Evidence of DOR Dimerization. BRET was
used to establish receptor interactions in our model system.
BRET titration experiments were performed with HEK293T
cells coexpressing constant amounts of DOR-RLuc8 and in-
creasing concentrations of DOR-mVenus. A saturable BRET
signal was observed for DOR-DOR (Figure S2A of the Sup-
porting Information). In addition, BRET experiments were
performed in the presence of untagged DOR, which inhibited
the BRET signal by competing for dimerization with the
receptors fused to the probes. Competition over the entire
titration range rules out changes in the absolute or relative levels
of expression of the BRET probes as the cause of the weakened
BRET signal (Figure S2B of the Supporting Information). The
BRET results are consistent with very close interactions between
DOR protomers and with previous findings (11, 50).
Cross-Linking of Substituted Cysteines at the Extracel-
lular Ends of TM4 and TM5. To characterize the interfaces of
DOR homodimers, we used cysteine cross-linking. Therefore, it
was essential to develop a system in which the background
receptor construct ran as a monomer on nonreducing SDS-
PAGE despite treatment with sulfhydryl-specific cross-linking
reagents. In preliminary experiments using stably expressed WT
DOR,weusedascross-linkingreagentsCuPandHgCl2.Inot h er
studies of membrane proteins, CuP was unable to cross-link
cysteines deep in the transmembrane domain, whereas HgCl2
efficiently cross-linked a group of these residues that were
inferred to be at an oligomeric interface (51, 52). Whereas
treatment with CuP failed to alter the monomeric species of
WTDOR,treatmentwithHgCl2resultedinasubstantialamount
of receptor migrating as a larger band of ∼110 kDa (Figure 2A),
consistent with the expected migration of a DOR homodimer
that is disulfide cross-linked via an endogenous cysteine. In
addition to the conserved C121
3.25-C198 disulfide bridge, six
endogenouscysteineresiduesarepresentinDORhelicesTM1and
TM4-TM7. Three cysteine residues in the extracellular regions of
TM1(C60
1.43),TM4(C171
4.48),andTM5(C216
5.41) wereselected
for mutation as they were lipid-exposed, and possibly involved in
dimeric interfaces involving TM1, TM4, or both TM4 and TM5,
as previously demonstrated for D2R (21, 22).
Simultaneousmutationofallthreeofthesecysteineresiduesto
serine (C60
1.43S/C171
4.48S/C216
5.41S) resulted in a background
construct (termed “pseudo-Cys-less”) that migrated almost ex-
clusivelyasaheterogeneouslyglycosylatedmonomerof∼52kDa
via nonreducing SDS-PAGE (Figure 2A) after treatment with
either CuP or HgCl2. To identify the cysteines that were cross-
linked in WT DOR, we generated the double mutant constructs
C60S
1.43S/C171
4.48S and C60
1.43S/C216
5.41S. Both of these con-
structs behaved like WT DOR, as their migration was unaltered
byCuP,but they migrated asa dimer aftertreatment with20μM
HgCl2 (Figure 2A), indicating that each of the endogenous
cysteines at positions 4.48 and 5.41 could be cross-linked by
HgCl2.
The pseudo-Cys-less (CL) construct was used for substituted
cysteine analysis to map in greater detail the 4 and 4/5 interfaces.
Several positions in TM4 and TM5 (including 4.56-4.63 and
5.38-5.40) were individually substituted with cysteine, and the
constructs were subcloned into the pcDNA5/FRT/TO expres-
sion vector and stably expressed in Flp-In T-REx HEK293 cells.
Cross-linking experiments were performed as for the WT and
background receptor constructs (Figure 2B). All of the1686 Biochemistry, Vol. 50, No. 10, 2011 Johnston et al.
substituted cysteines in the CL background were expressed and
led to a maturely glycosylated receptor, with the exception of
P182
4.59C, I183
4.60C, V185
4.62C, and K214
5.39C. Flow cytometry
analysis of the maturely glycosylated mutants showed robust
surfaceexpression(FigureS3oftheSupportingInformation).Of
these mutants, only V181
4.58C and T213
5.38C led to cross-linking
with both CuP and HgCl2 to a dimer band similar to that
observed with WT DOR (Figure 2B). None of the other mutants
were cross-linked by either reagent (data not shown; Table S1 of
the Supporting Information). The extent of cross-linking of
V181
4.58C, located at the extracellular end of TM4, was greater
than that for T213
5.38C. A number of factors may contribute to
thisdifference,including the local environment ofthe substituted
cysteines, the distance or the orientation of these cysteines at a
homodimer interface, and the stability of this interface.
We performed [
3H]naltrindole binding experiments to deter-
mine Kd and Bmax values for WT and the CL background
construct as well as the mutants that were cross-linked by CuP
(CL, V181
4.58C, and T213
5.38C). These mutants bound
[
3H]naltrindole with near-normal Kd and Bmax values (Table S2
of the Supporting Information), consistent with the flow cyto-
metry data described above (Figure S3 of the Supporting
Information). TheDORagonistSNC-80 led torobustactivation
of the WT and key mutants, which was measured using a G
protein BRET-based biosensor (33). The CL construct had a
somewhat diminished potency and efficacy, which curiously was
not seen in V181
4.58Ca n dT 2 1 3
5.38C, two mutations made in the
CL background. Taken together, our data demonstrate that the
key mutants express at the surface, bind the antagonist
[
3H]naltrindole normally, and are activated by the agonist
SNC-80, indicating that they are properly folded and interact
appropriately with G proteins.
Molecular Characterization of the 4 and 4/5 Dimers of
DOR. To select energetically favorable dimeric models of DOR
homodimers among all different possibilities amenable to TM4
interfaces involving either position 4.58 or 5.38, we used en-
hanced sampling algorithms working within the framework of
classical molecular dynamics. A flowchart of the modeling and
simulation strategy is provided in Figure S4 of the Supporting
Information. Specifically, we conducted well-tempered metady-
namicssimulationsofboth4and4/5dimersofDORinthephase
space defined by a small number of collective variables, applying
a Gaussian bias to the angle CVs describing the relative orienta-
tion of the DOR protomers (see full CV definitions in Materials
and Methods and Figure 1). To enable a thorough exploration
for each dimer in a reasonable time scale, we also applied
restraints to these CVs, as well as to the distance between proto-
mers. Specifically, the distance restraint was chosen such that it
limited the exploration to dimeric configurations of DOR
(i.e., <3.4 nm between the COMs of the protomers), while the
selectedanglerangesforeachoftheputativeDORdimerslimited
the search to an ∼25  interval around position 4.58 or an ∼17 
interval around position 5.38, to keep these positions within a
range of physical interaction (Cβ distance of e12 A ˚ ).
Thorough exploration of the conformational space available
totheinteractingDORprotomerswasverifiedbymonitoringthe
evolution of the CVs during simulations. Panels A and B of
Figure S5 of the Supporting Information show the evolution of
the CVs for the 4 and 4/5 dimers, respectively. Because Gaussian
bias was applied tothe angle CVs(θDOR1and θDOR2), wecan see
good exploration of the angle ranges for both θDOR1 and θDOR2
duringthesimulations,asevidencedbyrepeatedrecrossingofthe
available phase space, as defined by the two limiting potentials
(equivalent to ranges of ∼25  and 15 ,r e s p e c t i v e l y ) .
The free energy surface (FES) as a function of angles θDOR1
and θDOR2 (see Figure 3) was calculated, for each of the systems,
from the history of the biasing hills applied to the simulation.
Figure 3A reports the two-dimensional FES for the 4 dimer. As
shown in this figure, there are two well-defined basins, x and y,
exhibiting a free energy difference of ∼6 kcal/mol. The ranges of
angles (in degrees) for basin x are approximately as follows:
10.3  e θDOR1 e 14.3 , and 5.7  e θDOR2 e 12.6 .B a s i ny is
approximately positioned at the following angles: 21.2  e θDOR1
FIGURE 3: Free energy maps derived from the hills deposited during
the well-tempered metadynamics simulations of the coarse-grained
representationsofthe(A)4and(B)4/5interfaces.Theaxesrepresent
theanglesθDOR1 andθDOR2 asdefinedinthelegendofFigure1.Red
denotesthelowestenergyandbluethehighestenergy.Lowest-energy
regions are highlighted with labels.
FIGURE 2: Cross-linking of DOR to a homodimer by copper phe-
nanthroline (CuP) and mercuric chloride (HgCl2). (A) Treatment of
Myc-DOR and indicated mutant constructs with CuP or 20 μM
HgCl2.(B)Cross-linkingoftheDORTM4andTM5cysteinemutant
with CuP and 20 μMH g C l 2. Stably expressed cysteine mutants in
TM4 and TM5 were cross-linked with CuP at 25  C for 10 min, and
the reaction was stopped with N-ethylmaleimide and analyzed by
immunoblotting. All experiments were repeated at least three times,
and a representative experiment is shown.Article Biochemistry, Vol. 50, No. 10, 2011 1687
e 26.9 ,a n d1 8 . 3   e θDOR2 e 24.1 .T h i si si ns h a r pc o n t r a s tt o
Figure 3B, showing the FES for the 4/5 dimer. This FES shows
little detail, i.e., little variation in energy across the available
range of angles. We have selected a structure from a basin at the
following values: θDOR1 = 36.1  and θDOR2 = 17.2 .
Structureswereextractedfromthebasinsdescribedabove,and
example structures from the minima were reconstructed at
atomic resolution for each dimer (see Materials and Methods
for details). These structures were embedded into an explicit all-
atomPOPC/10%cholesterolmembrane,solvated,andsimulated
for 1 ns, as described in Materials and Methods.
FigureS6AoftheSupportingInformationshowsthedistances
among the DOR regions most involved in dimeric interaction
calculatedforthe4dimerduringa1nssimulation.Thegraylines
delimit the helices and loops. Contacts are colored gray if the
distancebetweentheCβatomofeachresidueis>15A ˚ .Contacts
at a Cβ-Cβ distance of <15 A ˚ are colored from blue to pink,
with decreasing contact distance. The tightest interactions are
shown along the full length of TM4, and between the C-terminal
end of TM4 and the N-terminal end of TM3 to EL1. There are
also several interactions of intracellular loop 2 (IL2), through
TM4,withthe C-terminal endofTM1 through IL1 toalmostthe
full length of TM2.
Table 1 shows the symmetrical interprotomer contacts
(distance between Cβ atoms of <15 A ˚ ) between residues facing
one another (i.e., the CR-CR distance longer than the Cβ-Cβ
distance, indicating that Cβ atoms point toward one another in
most residues, with the exception of glycines), during a 1 ns
simulation of the atomistic reconstructions of structures
extracted from the FES basins for each of the interfaces. In the
4 dimer, residues K166
4.43,I 1 7 0
4.47, S177
4.54,V 1 8 1
4.58,a n d
V185
4.62 are allin the proximity of their symmetrical counterpart
at the TM4 interface. These interactions are supported by other
symmetrical interactions among TM3, TM2, and extracellular
loop 2 (EL2). There is no clear predominance of any type of
residue, e.g., hydrophobic or polar, over any other type in this
interface. At first glance, some of the interactions may seem
unexpected, for example, a symmetrical interaction between two
lysine residues, as in the case of K166
4.43, but upon closer
inspection, it is apparent that the side chains lie adjacent to one
another and the charged regions interact with the backbone of
residues on the opposite protomer, tightening the interface. The
conserved tryptophan residues at the interface, W173
4.50,a r e
oriented in a configuration that could support π-π stacking,
which would also strengthen the interface.
Figure 4A shows the configurations representative of the
lowest-energy basin identified for the 4 dimer of DOR, with
residues that make up the interface (i.e., facing one another and
within 15 A ˚ of each other) color-coded according to their
proximity, as listed in Table 1. We highlight only the residues
fromtheTMandH8regionsforthesakeofsimplicity.Figure4B
shows the residues involved ininterprotomer interaction inthe 4/
5 dimer. As reported in Table 1, the 4/5 dimer presents several
symmetrical residues in spatial proximity along the length of
TM4 and some in TM5, but the interprotomeric interface
appears to be dominated by the spatial proximity of residues
on EL2. The contact map for the most involved regions in this
dimeric arrangement is shown in Figure S6B of the Supporting
Information. From this map, it is clear that the interface is
dominated by the extracellular region of the protomers, and that
thehelix-loopboundaryregionsofEL2playakeyroleinthe4/5
dimer. Although bending toward the binding pocket of the
receptor, both the N- and C-terminal ends of the EL2 loop
protrude across the interface toward the other protomer (see
Figure 4), hinderingtighterpacking between the helicesdeeperin
the membrane and at the intracellular ends of the protomers.
Strength of Association of the 4/5 Dimer Compared to
the 4 Dimer. To estimate the relative stability of the 4/5 dimer
versus the 4 dimer, we performed umbrella sampling simulations
of the CG 4/5 dimer in an explicit CG POPC/10% cholesterol
environment and compared the results of these simulations with
analogous simulations we recently conducted with the 4 dimer
(17). As shown in Figure 5, a single minimum was identified for
the 4/5dimer (blue line) at an energy higher than those of the two
energetically and structurally similar dimeric minima previously
identified for the 4 dimer (red line) (17). Using the calculated free
energy area for the 4/5 dimer from Figure 5 and the formalism
originally described by Roux and co-workers (47-49)a n d
recently applied by us to the 4 dimer of DOR (see details in
ref 17), we estimated a dimerization constant (KDimer)
of =0.05 μm
2fortheidentifiedlowest-energy4/5dimercompared
to the recently reported value of 1.02 μm
2 for the 4 dimer (17).
Using this dimerization constant in combination with a diffusion
coefficient of 0.08 μm
2/s determined experimentally for MOR
(15),wecalculatedahalf-timeof0.2sforthe4/5dimer,compared
to the value of 4.4 s previously reported for the 4 dimer (17).
DISCUSSION
We have used disulfide cross-linking of endogenous and
substituted cysteines to identify residues in TM4 and TM5 at
Table 1: Symmetrical Residues in Spatial Proximity (<15 A ˚ ) and Facing
One Another (the CR-CR distance longer than the Cβ-Cβ Distance) for
Each of the Putative 4 or 4/5 Interfaces during a 1 ns Explicit Atomic Scale
Simulation
a
TM4 TM4 and TM5 Cβ-Cβ (A ˚ )
K166 4.43 V188 EL2 <7
I170 4.47 P191 EL2
S177 4.54
V181 4.58
V185 4.62
P162 4.39 V179 4.56 7
W173 4.50 R192 EL2
V174 4.51
A163 4.40 D158 IL2 8
L175 4.52
I183 4.60
9
S126 3.30 C171 4.48 10
G178 4.55
M186 EL2
I86 2.41 T213 5.38 11
K122 3.26
A123 3.27
Q190 EL2
G178 4.55 K164 4.41 12
T189 EL2 I168 4.45
F220 5.45
N90 2.45 F159 IL2 13
V217 5.42
K81 IL1 K155 IL2 14
G180 4.57
S206 EL2
aThe last column gives their average proximity (Cβ-Cβ) during the
simulation.1688 Biochemistry, Vol. 50, No. 10, 2011 Johnston et al.
the interface of DOR homodimers. These findings were used to
guide a total of 3 μso fw e l l - t e m p e r e dm e t a d y n a m i c sC G
simulations to characterize at the atomic level the putative
interfaces between interacting protomers of the DOR. In accor-
dance with predictions from correlated mutation analysis of
ORs (53, 54), and with published experimental evidence for
severalGPCRdimersand/oroligomers(19-31),wefirstfocused
ontheTM4andTM5interfaces.Wediscoveredthatendogenous
cysteines at positions 4.48 and 5.41 were cross-linked by HgCl2
but not by CuP, consistent with the ability of HgCl2 to penetrate
deeper in the membrane and also with its ability to bridge more
distant cysteines that might not collide directly. Removal of the
three endogenous cysteines in TM1, TM4, and TM5 led to a
pseudo-Cys-less DOR; treatment with HgCl2 a n dC u Ph a dn o
effect on the migration of DOR on nonreducing SDS-PAGE.
This construct was used for subsequent cysteine substitution.
Substitutions V181
4.58Ca n dT 2 1 3
5.38C at the extracellular ends
of TM4 and TM5 led to cross-linking with both CuP and HgCl2,
providing further evidence of the role of these interfaces in DOR
homomerization. These findings are in general agreement with
our previous studies on D2R, which supported the direct
involvement of lipid-exposed surfaces of TM4 and/or TM5 in
dimerization/oligomerization interfaces (21, 22). However, it is
notable that the extent of cross-linking is lower in the DOR and
the residues that cross-link are much more limited in contrast to
the broad stripe of cross-linking detected in the D2R (20, 21).
Several residues in DOR such as G180
4.57,M 1 8 4
4.61,M 1 8 6
4.63,
and I215
5.40did not exhibitanyappreciablecross-linkingbyCuP
or HgCl2 when mutated to cysteine, despite their predicted
orientation on the same faces as V181
4.58 or T213
5.38. There are
a number of potential explanations for this more limited cross-
linking, including access of the reagents, the microenvironment
and ionization state of the cysteine, and the possibility that the
interfaces in the DOR may be more dynamic than that of the
D2R.
To investigate further details of these dynamic interfaces, we
exploredtheconformationalspaceaccessibletointeractingDOR
protomers centered at position 4.58 or 5.38. Our computational
results point to energetically preferred configurations of the 4
FIGURE 4: Residues at the 4 interface. (A, top) Residues of one protomer found to be within 15 A ˚ of their symmetric partners on the other
protomer, and facing each other. (A, bottom) Complete dimer as seen from the extracellular side. (B) Same information reported for the 4/5
interface. For the sake of clarity, only residues from the TM domain and H8 have been included.
FIGURE 5: Free energy of 4 (red) or 4/5 (blue) interprotomeric
arrangements of DOR restrained in their relative orientation by
square-well potentials applied on the rotational angles. For the sake
of simplicity, the curves are shifted to assign 0 values to monomeric
states (r g 4.5 nm).Article Biochemistry, Vol. 50, No. 10, 2011 1689
dimer that are characterized by specific residue interactions. In
line with the experiments, our computations are consistent with
the proximity (<7 A ˚ ) of V181
4.58 to its symmetrical counterpart,
during a 1 ns unrestrained all-atom simulation of the predicted
lowest-energy configuration of the 4 dimer in an explicit POPC/
10% cholesterol/solvent environment. Other very close residues
(<8 A ˚ ) predicted to face each other at this TM4 interface are
K166
4.43,I 1 7 0
4.47, S177
4.54,V 1 8 5
4.62,V 1 7 4
4.51,W 1 7 3
4.50,a n d
P162
4.39. The free energy surfaces generated from the metady-
namics calculations indicate that this proposed 4 dimer config-
uration of DOR corresponds to the lowest-energy minimum.
The free energy surface shown in Figure 3B for the 4/5 dimer
indicates there is little variation across the range of angles
representing this interface. Combined with the shorter lifetime
calculated for the 4/5 dimer and the weaker cross-linking at
position 5.38, as compared to those for the 4 dimer and the
residue at position 4.58, these findings suggest that the 4 dimer
interface is more specific than that of the 4/5 dimer. Unlike the
case of the 4 dimer, the closest interactions between residues at
the interface of the 4/5 dimer do not encompass the full
membrane span of the protomers (from extra- to intracellular
regions),thuscontributingtoitsreducedstability.Thecalculated
contact maps show that interfacial contacts in the 4/5 dimer are
dominated by the (more flexible) helix-loop boundary regions
for EL2, which might be expected to reduce the angle specificity,
when compared to the 4 dimer interface where the interactions
are predominantly helix-helix interactions.
Notably, our calculated lifetimes of DOR homodimers
approximate the association and dissociation kinetics of M1
muscarinic receptors assessed by single-molecule studies (12).
The lifetime of DOR homodimers appears to be relatively short.
Although the strength of DOR dimerization appears to depend
on the protein sequence at the interface, with the 4 dimer being
morestablethanthe4/5dimer,wecannotruleoutacontribution
of other factors, such as the hydrophobic mismatch between the
thicknesses of the receptor TM region and the lipid bilayer, to
receptor interactions.
Our computational results are consistent with the data we
obtained fromcysteinecross-linkingexperimentsconductedwith
DORandmightrelatetothemorelimitedcross-linkingobserved
in DOR relative to D2R (20, 21). To understand whether the
nature of interaction is similar for all GPCR pairs, additional
simulations on several different GPCR systems are currently
ongoing in our lab.
SUPPORTING INFORMATION AVAILABLE
Additional details concerning the results obtained are pro-
vided. Figure S1 shows hill heights (left panels) indicating
convergence of the simulations, as wellas the bias applied during
the simulations (right panels). Figure S2 depicts the results of
BRET titration experiments. Figure S3 shows surface expression
of mutants resulting from flow cytometry analysis. Figure S4
illustrates a flowchart of the modeling and simulation strategy.
Panels A and B of Figure S5 show the time evolution of θDOR1
(light gray) and θDOR2 (dark gray) for the 4 and 4/5 dimers,
respectively. Figure S6 reports contact maps of the protomeric
regions most involved in the (A) 4 and (B) 4/5 dimeric arrange-
ments calculated during 1 ns. The tables give details of the cross-
linking results for each mutant construct with the two different
reagents (Table S1), Kd and Bmax values for delta opioid receptor
WT and mutants obtained during saturation binding of
[
3H]naltrindole in intact cells (Table S2), and SNC-80-induced
activation of G protein by WT and key mutants, measured using
a BRET biosensor (Table S3). This material is available free of
charge via the Internet at http://pubs.acs.org.
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